WOMAC TM

Related by string. * Womac : McMaster Universities WOMAC . WOMAC scores . WOMAC pain . Index WOMAC . WOMAC / TMD . Tm . TMs . TMS . tm : FinancialWire tm website . Contact FinancialWire tm . TM EA SPORTS . Forrester Wave TM . Ibis T# TM Biosensor . Xerox Phaser TM . Addressing Psoriasis TM . Nintendo GameCube TM . Citrix Synergy TM . through eReleases TM . Impart IQ TM . AMD Opteron TM * *

Related by context. Frequent words. (Click for all words.) 63 PANSS 63 MADRS 63 Expanded Disability Status 63 Secondary endpoints included 63 Negative Syndrome 62 Global Impression 61 Disease Activity 61 Unified Parkinson Disease 61 WOMAC 61 ADAS cog 60 Secondary endpoints 59 DAS# [002] 59 HRQOL 59 annualized relapse 58 IPSS 57 TAXUS p value 57 Secondary endpoints include 57 QoL 56 plus prednisone 56 ADHD RS 56 symptom severity 55 placebo p 55 CI -#.# 54 univariate 54 erythrocyte sedimentation rate 54 plus methotrexate 54 Depression Rating Scale 54 primary efficacy endpoints 54 Main Outcome Measures 53 p = #.# [002] 53 fasting plasma glucose 53 fraction LVEF 53 tolvaptan 53 subscales 53 Rating Scale 53 placebo p = 53 ACR# response 53 HRQoL 52 Natalizumab 52 achieved statistical significance 52 sensitivity specificity 52 creatinine clearance 52 apolipoprotein B 52 P = .# 52 % CI #.#-#.# [003] 52 Natural Catastrophe Stress 52 left ventricular systolic 52 sd = 52 ACR# [002] 52 sensory neuropathy 51 p = .# [002] 51 Total Capitalization 51 mucosal healing 51 Response Evaluation Criteria 51 primary efficacy endpoint 51 infected aneurysms endocarditis 51 symptomatology 51 % CI #.#-#.# [007] 51 XIENCE V vs. 51 synovitis 51 fasting insulin 51 secondary endpoint 51 retinal thickness 51 plus dexamethasone 51 % CI #.#-#.# [006] 51 Postoperative 51 Prognostic 51 intermittent claudication 50 mg BID 50 sustained virologic response 50 mg QD 50 virologic response 50 p = #.# [004] 50 estimated glomerular filtration 50 Outcomes Study 50 rheumatoid factor 50 preoperatively 50 mortality morbidity 50 serum testosterone 50 demonstrated statistically significant 50 glycosylated hemoglobin 50 HbA1C 50 HbA 1c 50 peripheral edema 50 serum sodium 50 biochemical recurrence 50 PREZISTA r 50 paresthesia 50 PsA 49 ± SD 49 serum uric acid 49 postop 49 #mg/day [001] 49 lymphopenia 49 dyspnea 49 laboratory abnormalities 49 hyperglycaemia 49 concomitant medications 49 confidence interval #.#-#.# 49 hypokalemia 49 Depression Inventory

Back to home page